Avadomide (CC-122)

Ask supplier a question | View on supplier's website
Avadomide (CC-122), a new chemical entity termed pleiotropic pathway modifier, is a novel agent for Diffuse large B-cell lymphoma(DLBCL) with antitumor and immunomodulatory activity. Its molecular target is the protein cereblon (CRBN), a substrate receptor of the cullin ring E3 ubiquitin ligase complex CRL4CRBN.
Supplier Selleck Chemicals
Product # S7892
Sku # S7892-2mg
Pricing 2mg, $70.00

Citations for this product:

Feedback